![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 24, 22053-22062, June 14, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Steroid Hormones Section, NIDDK/Laboratory of
Molecular and Cellular Biology, National Institutes of Health,
Bethesda, Maryland 20892
GMEB-1 was initially described as a
component of a 550-kDa heteromeric DNA binding complex that is involved
in the modulation of two properties of glucocorticoid receptor (GR)
transactivation, the dose-response curve of agonists and the partial
agonist activity of antagonists. Subsequently, GMEB-1 was also found to
bind to hsp27, to associate with the coactivator TIF2 in yeast cells, and to participate in Parvovirus replication. To
understand these multiple activities of GMEB-1 at a molecular level, we
have now determined which regions are associated with the various
activities associated with the modulation of GR transactivation
properties. These activities include, homooligomerization,
heterooligomerization, DNA binding, binding to GR and the
transcriptional cofactor CBP, and GR modulation. Complex activities
such as DNA binding and GR modulation, are found to require the
physical combination of those domains that would be predicted from the
involved biochemical processes. We have previously documented that
GMEB-1 possesses both GR modulatory and intrinsic transactivation
activity. However, the domains for these two activities of GMEB-1 are
found not to overlap. This separation of activities provides a
structural basis for our prior biological observations that the
modulation of the dose-response curve and partial agonist activity of
GR complexes is independent of the total levels of gene activation by
the same GR complexes.
To whom correspondence should be addressed: Bldg. 8, Rm. B2A-07,
NIDDK/LMCB, NIH, Bethesda, MD 20892. Tel.: 301-496-6796; Fax:
301-402-3572; E-mail: steroids@helix.nih.gov.
This article has been cited by other articles:
![]() |
K. Tsuruma, T. Nakagawa, N. Morimoto, M. Minami, H. Hara, T. Uehara, and Y. Nomura Glucocorticoid Modulatory Element-binding Protein 1 Binds to Initiator Procaspases and Inhibits Ischemia-induced Apoptosis and Neuronal Injury J. Biol. Chem., April 21, 2006; 281(16): 11397 - 11404. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cho, B. L. Kagan, J. A. Blackford Jr., D. Szapary, and S. S. Simons Jr. Glucocorticoid Receptor Ligand Binding Domain Is Sufficient for the Modulation of Glucocorticoid Induction Properties by Homologous Receptors, Coactivator Transcription Intermediary Factor 2, and Ubc9 Mol. Endocrinol., February 1, 2005; 19(2): 290 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Jensik, J. I. Huggenvik, and M. W. Collard Identification of a Nuclear Export Signal and Protein Interaction Domains in Deformed Epidermal Autoregulatory Factor-1 (DEAF-1) J. Biol. Chem., July 30, 2004; 279(31): 32692 - 32699. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, J. A. Blackford Jr., L.-N. Song, Y. Huang, S. Cho, and S. S. Simons Jr. Equilibrium Interactions of Corepressors and Coactivators with Agonist and Antagonist Complexes of Glucocorticoid Receptors Mol. Endocrinol., June 1, 2004; 18(6): 1376 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Surdo, M. J. Bottomley, M. Sattler, and K. Scheffzek Crystal Structure and Nuclear Magnetic Resonance Analyses of the SAND Domain from Glucocorticoid Modulatory Element Binding Protein-1 Reveals Deoxyribonucleic Acid and Zinc Binding Regions Mol. Endocrinol., July 1, 2003; 17(7): 1283 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He, D. Szapary, and S. S. Simons Jr. Modulation of Induction Properties of Glucocorticoid Receptor-Agonist and -Antagonist Complexes by Coactivators Involves Binding to Receptors but Is Independent of Ability of Coactivators to Augment Transactivation J. Biol. Chem., December 13, 2002; 277(51): 49256 - 49266. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |